Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
August 4, 2004
Date of Report (Date of earliest event reported)
VIROLOGIC, INC.
| Delaware | 000-30369 | 94-3234479 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
345 Oyster Point Blvd.
South San Francisco, California 94080
(650) 635-1100
(Address, including zip code, and telephone number, including area code, of principal executive officers)
N/A
(Former name or former address, if changed since last report)
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 12. Results of Operations and Financial Condition. | ||||||||
| SIGNATURE | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
Table of Contents
Item 7. Financial Statements and Exhibits.
| 99.1 | Press release issued August 4, 2004. |
Item 12. Results of Operations and Financial Condition.
The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
On August 4, 2004, ViroLogic, Inc. issued a press release announcing its unaudited financial results for the quarter ended June 30, 2004. A copy of the press release is attached to this report as an exhibit.
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VIROLOGIC, INC. | ||||
| Dated: August 4, 2004 | By: | /s/ William D. Young | ||
| William D. Young Chief Executive Officer | ||||